The discovery of gene driver mutations and the increase of next-generation sequencing techniques have radically changed the natural history of NSCLCs. Neuroendocrine lung cancers are a heterogeneous entity whose biology is little known. Sporadic actionable mutations are also reported in this subtype of neoplasms, especially in tumors derived from a transformation of adenocarcinomas. ROS-1 gene rearrangements are found in about 1-2% of lung neoplasms and are characterized by a high sensitivity to specific tyrosine kinase inhibitors (TKis). Here we report the case of a large cell neuroendocrine carcinoma precisely framed and treated thanks to a next-generation genomic approach.

Comprehensive genomic profiling in large cell neuroendocrine lung cancer: the times they are a-changin' / Filetti, M.; Piras, M.; Giusti, R.. - In: RECENTI PROGRESSI IN MEDICINA. - ISSN 0034-1193. - 112:1(2021), pp. E1-E4. [10.1701/3525.35130]

Comprehensive genomic profiling in large cell neuroendocrine lung cancer: the times they are a-changin'

Filetti M.
Primo
;
Piras M.;
2021

Abstract

The discovery of gene driver mutations and the increase of next-generation sequencing techniques have radically changed the natural history of NSCLCs. Neuroendocrine lung cancers are a heterogeneous entity whose biology is little known. Sporadic actionable mutations are also reported in this subtype of neoplasms, especially in tumors derived from a transformation of adenocarcinomas. ROS-1 gene rearrangements are found in about 1-2% of lung neoplasms and are characterized by a high sensitivity to specific tyrosine kinase inhibitors (TKis). Here we report the case of a large cell neuroendocrine carcinoma precisely framed and treated thanks to a next-generation genomic approach.
2021
crizotinib; driver mutations; gene sequencing; LCNEC; molecular target therapy; ROS-1
01 Pubblicazione su rivista::01i Case report
Comprehensive genomic profiling in large cell neuroendocrine lung cancer: the times they are a-changin' / Filetti, M.; Piras, M.; Giusti, R.. - In: RECENTI PROGRESSI IN MEDICINA. - ISSN 0034-1193. - 112:1(2021), pp. E1-E4. [10.1701/3525.35130]
File allegati a questo prodotto
File Dimensione Formato  
Filetti_Genomic-profiling_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 168.4 kB
Formato Adobe PDF
168.4 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1603205
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact